Skip to main content
Signal8

Fresenius Medical Care AG (FMS)

Fresenius Medical Care AG & Co. KGaA specializes in comprehensive kidney dialysis treatment and associated services, operating across Germany, North America, and numerous international territories. Through an extensive network of outpatient clinics, it delivers essential dialysis therapy along with laboratory and diagnostic support. For home-based care, the company supplies necessary equipment, provides comprehensive training, and offers ongoing patient assistance, including clinical oversight and coordinating supply deliveries directly to patients. In the United States, Fresenius Medical Care also contracts with hospitals to provide vital dialysis interventions for hospitalized individuals suffering from end-stage renal disease (ESRD) and acute kidney failure. Beyond services, it is a prominent developer, manufacturer, and distributor of a broad range of dialysis products. This portfolio encompasses polysulfone dialyzers, hemodialysis machines, peritoneal dialysis cyclers and solutions, concentrates, bloodlines, renal pharmaceuticals, and water treatment systems. Additionally, the company produces non-dialysis medical devices, including acute cardiopulmonary and apheresis products. Its pharmaceutical division focuses on developing, acquiring, and in-licensing specialized renal medications, distributing these essential drugs and supplies to both individual patients' homes and dialysis centers. The company also extends its medical offerings to include a variety of specialized services such as vascular, cardiovascular, and endovascular care, operating ambulatory surgery centers for vascular procedures, and providing physician services in nephrology and cardiology. Products are sold directly to dialysis clinics, hospitals, and specialized treatment centers, complemented by sales through local teams, independent distributors, dealers, and agents. By February 23, 2022, Fresenius Medical Care managed an impressive network of 4,171 outpatient dialysis clinics across roughly 150 countries. Established in 1996, the company maintains its headquarters in Bad Homburg, Germany.

Sector: Services-Misc Health & Allied Services, NEC

Fresenius Medical Care AG logo

Fresenius Medical Care AG

NYSE:FMS
-1.10%$23.40
CLOSED
AH$23.35-0.21%vs close
Mkt Cap$12.15B
Float532.21M
O/S519.02M
VOL1.09M sh
$ Vol$25.44M
RVOL0.78×
Inst Own8.7%
SI0.7%
Div Yield3.69%
Dilution
Fresenius Medical Care AG logoNYSE:FMSClosed$23.40-1.10%
FormDescription
6-K
6-K
6-K
6-K
6-K
13D/A
Beneficial Ownership Report (Active, Amended)
6-K
6-K
6-K
6-K
6-K
13G
Beneficial Ownership Report
11-K
SEC Filing
1
6-K
SD
SEC Filing
6-K
6-K
6-K
6-K
Foreign Private Issuer Report
3
OWNERSHIP DOCUMENT
6-K
Foreign Private Issuer Report
IRANNOTICE
SEC Filing
20-F
Foreign Annual Report
6-K
Foreign Private Issuer Report
6-K
Foreign Private Issuer Report

1-25 of 600

…

Recent SEC filings with analysis

    Fresenius Medical Care AG (FMS) SEC Filings: 10-K, 10-Q, 8-K, Form 4 | Signal8